BioCentury | Jun 15, 2009
Company News

Concateno, Inverness deal

...Inverness will acquire drug abuse testing company Concateno in a cash and stock deal of about...
...to Concateno's close of 107p on June 4, the day before the deal was announced. Concateno...
...in 3Q09. IDJ International advised Inverness while Collins Stewart and UBS Investment Bank advised Concateno. Concateno plc...
BioCentury | Sep 24, 2007
Company News

Concateno board of directors update

Concateno plc (LSE:COT), London, U.K. Business: Diagnostic Appointed: Neil Elton as finance director, former finance director at Mecom Group plc WIR Staff Diagnostic...
BioCentury | Sep 10, 2007
Company News

Concateno, Cozart deal

...RapiScan saliva-based test system. Collins Stewart is advising COT, and Numis Securities is advising CZT. Concateno plc...
Items per page:
1 - 3 of 3
BioCentury | Jun 15, 2009
Company News

Concateno, Inverness deal

...Inverness will acquire drug abuse testing company Concateno in a cash and stock deal of about...
...to Concateno's close of 107p on June 4, the day before the deal was announced. Concateno...
...in 3Q09. IDJ International advised Inverness while Collins Stewart and UBS Investment Bank advised Concateno. Concateno plc...
BioCentury | Sep 24, 2007
Company News

Concateno board of directors update

Concateno plc (LSE:COT), London, U.K. Business: Diagnostic Appointed: Neil Elton as finance director, former finance director at Mecom Group plc WIR Staff Diagnostic...
BioCentury | Sep 10, 2007
Company News

Concateno, Cozart deal

...RapiScan saliva-based test system. Collins Stewart is advising COT, and Numis Securities is advising CZT. Concateno plc...
Items per page:
1 - 3 of 3